Category: news feed

  • Gut Microbiota Modulation for Post-Acute COVID-19 Syndrome: Current Evidence

    Gut Microbiota Modulation for Post-Acute COVID-19 Syndrome: Current Evidence

    Post-acute COVID-19 syndrome (“long COVID”) refers to long-term symptoms that persist after acute SARS-CoV-2 infection, affecting multiple organs and systems. Long COVID affects over 65 million people worldwide, yet effective treatment is limited. Our research team at the Faculty of Medicine of the Chinese University of Hong Kong (CUHK Medicine) has completed a large-scale double-blind, randomised, placebo-controlled clinical trial, which confirmed that patients who were given an oral synbiotic preparation (SIM01) developed by CUHK experienced significant alleviation in various long COVID symptoms…

    (more…)

  • 透過改善腸道微生態紓緩新冠肺炎長期綜合後遺症:目前的研究進展

    透過改善腸道微生態紓緩新冠肺炎長期綜合後遺症:目前的研究進展

    新冠肺炎長期綜合後遺症是指新冠病毒感染後長期持續而影響多個器官的症狀,又稱「長新冠」。長新冠影響全球超過6,500萬人,但仍缺乏有效的治療方法。香港中文大學醫學院的研究團隊完成了一項大型的雙盲、隨機、安慰劑對照臨床研究,證實患者透過服用香港中文大學研發的口服合生製劑(SIM01)有效紓緩多種長新冠症狀…

    (more…)

  • 透过改善肠道微生态纾缓新冠肺炎长期综合后遗症:目前的研究进展

    透过改善肠道微生态纾缓新冠肺炎长期综合后遗症:目前的研究进展

    新冠肺炎长期综合后遗症是指新冠病毒感染后长期持续而影响多个器官的症状,又称「长新冠」。长新冠影响全球超过6,500万人,但仍缺乏有效的治疗方法。香港中文大学医学院的研究团队完成了一项大型的双盲、随机、安慰剂对照临床研究,证实患者透过服用香港中文大学研发的口服合生制剂(SIM01)有效纾缓多种长新冠症状…

    (more…)

  • Gut Microbiota Modulation for Post-Acute COVID-19 Syndrome: Current Evidence

    Gut Microbiota Modulation for Post-Acute COVID-19 Syndrome: Current Evidence

    Post-acute COVID-19 syndrome (“long COVID”) refers to long-term symptoms that persist after acute SARS-CoV-2 infection, affecting multiple organs and systems. Long COVID affects over 65 million people worldwide, yet effective treatment is limited. Our research team at the Faculty of Medicine of the Chinese University of Hong Kong (CUHK Medicine) has completed a large-scale double-blind, randomised, placebo-controlled clinical trial, which confirmed that patients who were given an oral synbiotic preparation (SIM01) developed by CUHK experienced significant alleviation in various long COVID symptoms…

    (more…)

  • 透過改善腸道微生態紓緩新冠肺炎長期綜合後遺症:目前的研究進展

    透過改善腸道微生態紓緩新冠肺炎長期綜合後遺症:目前的研究進展

    新冠肺炎長期綜合後遺症是指新冠病毒感染後長期持續而影響多個器官的症狀,又稱「長新冠」。長新冠影響全球超過6,500萬人,但仍缺乏有效的治療方法。香港中文大學醫學院的研究團隊完成了一項大型的雙盲、隨機、安慰劑對照臨床研究,證實患者透過服用香港中文大學研發的口服合生製劑(SIM01)有效紓緩多種長新冠症狀…

    (more…)

  • 透过改善肠道微生态纾缓新冠肺炎长期综合后遗症:目前的研究进展

    透过改善肠道微生态纾缓新冠肺炎长期综合后遗症:目前的研究进展

    新冠肺炎长期综合后遗症是指新冠病毒感染后长期持续而影响多个器官的症状,又称「长新冠」。长新冠影响全球超过6,500万人,但仍缺乏有效的治疗方法。香港中文大学医学院的研究团队完成了一项大型的双盲、随机、安慰剂对照临床研究,证实患者透过服用香港中文大学研发的口服合生制剂(SIM01)有效纾缓多种长新冠症状…

    (more…)

  • Alpacas and Nanobodies

    Alpacas and Nanobodies

    When we think of alpacas, the first things that pop up in our minds may be holiday farms or alpaca fleece. However, if you ask a biomedical scientist, they may have thought of nanobody, fragment of a special type of antibody…

    (more…)

  • 羊駝與奈米抗體

    羊駝與奈米抗體

    談及羊駝,我們通常會想到假日農場或羊駝絨,但如果你問生物醫學範疇的科學家的話,他們卻可能會想起一種特殊抗體的片段 — 奈米抗體…

    (more…)

  • 羊驼与奈米抗体

    羊驼与奈米抗体

    谈及羊驼,我们通常会想到假日农场或羊驼绒,但如果你问生物医学范畴的科学家的话,他们却可能会想起一种特殊抗体的片段 — 奈米抗体…

    (more…)

  • Alpacas and Nanobodies

    Alpacas and Nanobodies

    When we think of alpacas, the first things that pop up in our minds may be holiday farms or alpaca fleece. However, if you ask a biomedical scientist, they may have thought of nanobody, fragment of a special type of antibody…

    (more…)